Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

2.110 -0.040 (-1.86%)
Streaming Delayed Price Updated: 10:02 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cerus Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
News headline image
Delta Variant Fears Continue ↗
The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher. 
Via Talk Markets
News headline image
Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors
From Cerus Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6... 
Via Benzinga
News headline image
88 Biggest Movers From Yesterday ↗
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
30 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 34.8% to $1.84 in pre-market trading after gaining around 3% on Tuesday. Wheeler Real Estate Investment Trust,... 
Via Benzinga
News headline image
Cerus Stock Gains As Q2 Earnings Match Expectations, Raises FY21 Sales Guidance ↗
Cerus Corporation (NASDAQ: CERS) reported second-quarter sales of $37.8 million, +41% Y/Y in line with the consensus. Product revenue reached $31.5 million, compared to... 
Via Benzinga
Topics Earnings
News headline image
Cerus Corporation (CERS) Q2 2021 Earnings Call Transcript ↗
CERS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Cerus (NASDAQ:CERS) shares incre... 
Via Benzinga
News headline image
14 Stocks Moving In Tuesday's After-Hours Session ↗
RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY21 EPS and sales guidance above... 
Via Benzinga
News headline image
Recap: Cerus Q2 Earnings ↗
Shares of Cerus (NASDAQ:CERS) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to... 
Via Benzinga
News headline image
Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021
From Cerus Corporation
Via Business Wire
News headline image
Delta Defeats Bulls ↗
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
News headline image
Weak Week ↗
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... 
Via Benzinga
Topics Product Recall
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was the largest firm by market cap to set a new 52-week low.... 
Via Benzinga
News headline image
Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets
From Cerus Corporation
Via Business Wire
News headline image
Cramer Gives His Opinion On AT&T, Cemex And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a fan of AT&T Inc. (NYSE: T). For growth, he would go with T-Mobile Us Inc (NASDAQ: TMUS) and... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
News headline image
End Of June ↗
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT® Fibrinogen Complex
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Celebrates World Blood Donor Day 2021
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.